Neostigmine bromide produced very little inhibition of hydrolysing activity with ACh in Echinoderma asperum and no inhibition in Clitocybe phaeophthalma. Against acetylcholinesterase from Electrophorus electricus, the reported IC50 was 0.06 ± 0.01 mg/mL. In rat brain homogenate, FRC and FRH extracts showed significantly lower inhibitory activities than Neostigmine bromide, which served as the standard acetylcholinesterase inhibitor. [1,2,3]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Limited inhibition of hydrolysing activity in Echinoderma asperum
Cell-based study · Echinoderma asperum [1]
In Echinoderma asperum, Neostigmine bromide at 1 mM produced very little inhibition of hydrolysing activity with ACh, reaching up to 20–30%.
Literature-Reported Treatment Conditions
- Treatment concentration
- 1 mM
- Exposure duration
- a 15-min endogenous reaction; 25°C for 15 min
- Method
- 10 μL of inhibitor
- Vehicle
- dH2O
Methods and source locations
Compound reported in the paper: Neostigmine bromide
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and methods > Inhibition of ChE-like activities (S43, S44, S45, S46, S47, S48); Results > Influence of different inhibitors on ChE-like activity in mushroom aqueous extracts (S86); Fig 4 legend (S120)
hydrolysing activity with ACh: hydrolysing activity with ACh; comparator: buffer (100 mM, pH 7.4) instead of inhibitor — Results > Influence of different inhibitors on ChE-like activity in mushroom aqueous extracts (S86)
Acetylcholinesterase inhibition in Electrophorus electricus
Cell-based study · Acetylcholinesterase (AChE) from Electrophorus electricus [2]
Neostigmine bromide was mixed and incubated with acetylcholinesterase from Electrophorus electricus. The reported half-maximal inhibitory concentration was 0.06 ± 0.01 mg/mL.
Literature-Reported Treatment Conditions
- Exposure duration
- 15 min at 25 °C
- Method
- mixed and incubated
- Reported limits
- Not stated in the sentences used: dose, vehicle.
Methods and source locations
Compound reported in the paper: Neostigmine bromide
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
3. Materials and Methods > 3.1. Materials > 3.1.2. Chemicals (S4); 3. Materials and Methods > 3.8. Anti-Enzymatic Activities > 3.8.1. Acetylcholinesterase (AChE) Inhibition Assay (S85, S86, S87, S89, S90, S91); Table 4 (T4.h1, T4.r11)
percent inhibition of acetylcholinesterase enzyme: percent inhibition of acetylcholinesterase enzyme; comparator: the assay using the buffer instead of inhibitor (sample) — 3. Materials and Methods > 3.8. Anti-Enzymatic Activities > 3.8.1. Acetylcholinesterase (AChE) Inhibition Assay (S89); Table 4 (T4.h1, T4.r11)
Neostigmine comparator in rat brain homogenate
Cell-based study · rat brain homogenate [3]
Neostigmine bromide was used as positive control. Both the extracts (FRC and FRH): their inhibitory activities were significantly lower (P ≤ 0.001) than that of neostigmine bromide, a standard acetylcholinesterase inhibitor.
Literature-Reported Treatment Conditions
- Exposure duration
- incubated for 5 min at 25°C
- Vehicle
- 0.1 mM sodium phosphate buffer (pH 8.0)
- Reported limits
- Not stated in the sentences used: dose, route.
Methods and source locations
Compound reported in the paper: Neostigmine bromide
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
MATERIALS AND METHODS > In vitro acteylcholinesterase inhibition assay (S8); MATERIALS AND METHODS > Assay procedure (S11, S12, S14, S16, S17); RESULTS (S21, S22)
percentage Inhibition of cholinesterase activity: percentage Inhibition of cholinesterase activity; comparator: control reaction (containing all reagents except the test compound) — MATERIALS AND METHODS > Assay procedure (S14); RESULTS (S21, S22)
No inhibition of hydrolysing activity in Clitocybe phaeophthalma
Cell-based study · Clitocybe phaeophthalma [1]
In Clitocybe phaeophthalma, Neostigmine bromide at 1 mM showed no inhibition of hydrolysing activity with ACh.
Literature-Reported Treatment Conditions
- Treatment concentration
- 1 mM
- Exposure duration
- a 15-min endogenous reaction; 25°C for 15 min
- Method
- 10 μL of inhibitor
- Vehicle
- dH2O
Methods and source locations
Compound reported in the paper: Neostigmine bromide
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and methods > Inhibition of ChE-like activities (S43, S44, S45, S46, S47, S48); Results > Influence of different inhibitors on ChE-like activity in mushroom aqueous extracts (S86); Fig 4 legend (S120)
hydrolysing activity with ACh: hydrolysing activity with ACh; comparator: buffer (100 mM, pH 7.4) instead of inhibitor — Results > Influence of different inhibitors on ChE-like activity in mushroom aqueous extracts (S86)